-
Mashup Score: 3Pfizer seeks authorization for updated Covid vaccine, without fresh clinical trial data - 3 year(s) ago
Pfizer and BioNTech said that they have asked the FDA to authorize a new booster shot targeted at the Omicron BA.4/BA.5 strain of the coronavirus that causes Covid-19.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5
The company and its partner, Pfizer, are preparing for the potential launch of 2 variant-adapted bivalent COVID-19 vaccines assuming authorizations from FDA and EMA.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1
The company and its partner, Pfizer, are preparing for the potential launch of 2 variant-adapted bivalent COVID-19 vaccines assuming authorizations from FDA and EMA.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Reporting of allergic reactions during Pfizer-BioNTech BNTT162B2 vaccination in Israel - 3 year(s) ago
In December 2020 the Israeli Ministry of Health (IMoH) launched a national vaccination campaign against SARS-CoV-2. Concomitant sporadic reports on anaphylactic responses in other countries raised safety concerns at the outset of this operation.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 3Pharmalittle: Pfizer and BioNTech seek Covid-vaccine use in kids under 5; Pfizer refunds $290,000 over misleading coupons - 3 year(s) ago
Pfizer and BioNTech expect to complete their submission for emergency authorization of their Covid-19 vaccine for children under 5 this week.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0COVID-19 vaccination in the setting of mastocytosis—Pfizer-BioNTech mRNA vaccine is safe and well tolerated - 3 year(s) ago
Mastocytosis refers to a heterogeneous group of disorders characterized by accumulation and activation of mast cells (MCs) in the skin and/or internal organs.1 Patients with clonal MCs limited to the skin are classified as having cutaneous mastocytosis, whereas in systemic mastocytosis (SM), at least 1 extracutaneous organ is involved.1 Furthermore, monoclonal mast cell activation syndrome (MMAS)…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Elodie Lellig, MD Elodie LelligAffiliationsDepartment of Dermatology and allergology, University Hospital of Nancy, France, rue de Morvan 54511 Vandœuvre-lès-Nancy, FranceClaudie Mouton-Faivre, MD Claudie Mouton-FaivreAffiliationsDepartment of Dermatology and allergology, University Hospital of Nancy, France, rue de Morvan…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0COVID-19 vaccination in the setting of mastocytosis - Pfizer-BioNTech mRNA vaccine is safe and well-tolerated - 3 year(s) ago
Article InfoPublication HistoryAccepted: January 17, 2022Received in revised form: January 4, 2022Received: November 12, 2021Publication stageIn Press Journal Pre-ProofFootnotesFunding sources: T. Gülen was supported by grants from the Konsul T.H.C. Bergh Foundation, Sweden, the Swedish Society of Medicine, and the Stockholm…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 3As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear - 3 year(s) ago
Pfizer expects initial findings from the study, which will enroll 1,420 volunteers in three cohorts, to be available during the first half of 2022. How soon regulators could authorize an Omicron-specific vaccine is unclear.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2
Colorectal cancer was chosen by BioNTech as an experimental vaccine target due to the disease’s relatively high relapse rate.
Source: interestingengineering.comCategories: Healthcare Professionals, Latest HeadlinesTweet
#Pfizer and #BioNTech said that they have asked the FDA to authorize a new booster shot targeted at the #Omicron BA.4/BA.5 strain of the coronavirus that causes Covid-19. https://t.co/UZ450CSTSo